Answer
Evidence is limited. UK rheumatology guidance considers IL-1 inhibitors compatible with breastfeeding, while the product information advises an individual benefit–risk assessment with the specialist team.
Sources for this answer
- Ilaris 150mg Solution for Injection in pre-filled Pen — Current selected SmPCemc · Summary of Product Characteristics
- PubMed CentralPubMed Central · Reputable Web
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.